(Cost)effectiveness of a cognitive group prevention module for recurrent depression.

Completed

• Conditions: Treatment as usual versus treamt as usual + cognitive therapy.

• Registration Number: NL-OMON27974

Brief Summary

1. Bockting, CLH, Schene, AH, Spinhoven, Ph, Koeter, MWJ, Wouters, LF, Huyser, J, & Kamphuis, JH: Preventing relapse/recurrence in recurrent depression using cognitive therapy. J Cons Clin Psychology 2005;73: 647-657. <br> 2. Bockting, CLH, Spinhoven, Ph, Koeter, MWJ, Wouters, LF, Visser, I, Schene, AH & the DELTA study group: Differential predictors of response to preventive cognitive therapy in recurrent depression: a 2-year prospective study, accepted for publication, Psychotherapy and Psychosomatic, july 2005.<br> 3. Bockting, CLH, Spinhoven, Ph, Koeter, MWJ, Wouters, LF, Schene, AH & the DELTA study group: Prediction of recurrence in recurrent depression and the influence of consecutive episodes on vulnerability: a 2-year prospective study, resubmitted Journal of Clinical Psychiatry, october 2005.<br> 4. Bockting, C., Schene, A.H., Huyser, J., Spinhoven, P. en de DELTA-studiegroep (2005). Recidiverende depressie: herstel en terugval in een Nederlands cohort. In: F. Boer, T.J. Heeren, J.P.C. Jaspers, B. Sabbe & J. van Weeghel (eds.). Jaarboek voor psychiatrie en psychotherapie 2005-2006. Houten: Bohn, Stafleu en Van Loghum, pp. 99-115. <br> 5. Huyser, J., Schene, A.H., Bockting, C., (2001). Recidiverende depressieve stoornissen: beloop en predictoren. In: Schene, A.H., F. Boer, T.J. Heeren, J.P.C. Henselmans, H.W.J., Trijsburg, R.W., Vandereycken, W., van der velden, K. (eds.). Jaarboek voor psychiatrie en psychotherapie 2001-2002. Houten: Bohn, Stafleu en Van Loghum, pp. 21-40. <br> 6. Bockting, C.l.H. Cognitieve therapie b&#307; depressie, (2003). Uitgever : Amsterdam : Psychiatrie AMC/De Meren.<br> 7. Huyser, J., Schene, A.H., Bockting, C., (2003) Behandelingstrategieën bij chronische depressie en dysthymie. In: Dagbehandeling en klinische opname bij chronische depressie. Bohn Stafleu Van Loghum, Houten/Diegem 2003, p. 101-112.<br> 8. Bockting, C.l.H, Schene, A.H., Spinhoven, Ph., e.a. J of Consulting and Clinical Psychology, 2005;73: 647-657.

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 February 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 187

Inclusion Criteria

To be eligible, patients had to meet the following criteria:

1. Experienced at least two Major Depressive Episodes (MDEs) in the previous five years, as defined according to the Diagnostic and Statistical Manual of mental Disorders (DSM-IV: American Psychiatric Association, 1994) and assessed with the Structured Clinical Interview for DSM-IV (SCID; First, Gibbon, Spitzer, & Williams, 1996) administered by trained interviewers;

Exclusion Criteria

Exclusion criteria were current mania or hypomania or a history of bipolar illness, any psychotic disorder (current and previous), organic brain damage, alcohol or drug misuse, predominant anxiety disorder, recent ECT, recent cognitive treatment or receiving CT at the start of the study, or current psychotherapy with a frequency of more than two times a month.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Relapse/recurrence To assess relapse/recurrence, we used the Structured Clinical Interview for DSM-IV (SCID-I; First, Gibbon, Spitzer, & Williams, 1996) was used. At baseline and at three follow-up assessments (3, 12, and 24 months), current and past depressive episodes were checked.

Secondary Outcome Measures

Name	Time	Method
The number of relapse/recurrence and severity relapse/recurrence.